Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | PNLIP | P16233 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 0.79 |
| ▸ | XBP1 | P17861 | 2/20 | 0.79 |
| ▸ | GAA | P10253 | 2/20 | 0.79 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.79 |
| ▸ | IDE | P14735 | 1/20 | 0.79 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 2/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mahanimbine SCHEMBL18488200 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1PNLIPPOLB | |
| Mahanimbine SCHEMBL18488203 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL20434657 | 0.89 | MAPT (0.84) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL13142229 | 0.88 | MAPT (1.00) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL18317471 | 0.88 | MAPT (1.00) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL13344164 | 0.88 | MAPT (1.00) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL31723092 | 0.86 | MAPT (0.73) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL31723084 | 0.81 | MAPT (0.71) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL25937950 | 0.80 | MAPT (0.72) | MAPTKMT2AMEN1PNLIPPOLB | |
| SCHEMBL30366382 | 0.79 | KMT2A (0.66) | MAPTKMT2AMEN1PNLIPPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4647073-A1 | MURRAYA KOENIGII IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS | Nutraceutical Technology Pharma Biotech S.r.l. (IT) | 2025-11-12 | — | — | EP | claimed |
| US-20220143124-A1 | SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION | LAILA NUTRACEUTICALS (IN) | 2022-05-12 | — | — | US | claimed |
| WO-2020202211-A1 | SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION | LAILA NUTRACEUTICALS (IN) | 2020-10-08 | — | — | WO | claimed |
| US-20180296490-A1 | BIOACTIVE DELIVERY VEHICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-10-18 | — | — | US | claimed |
| EP-3212159-A1 | BIOACTIVE DELIVERY VEHICLES | The Regents of the University of California (US) | 2017-09-06 | — | — | EP | claimed |
| WO-2016069740-A1 | BIOACTIVE DELIVERY VEHICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-05-06 | — | — | WO | claimed |
| US-20150050371-A1 | Extract Formulations of Rhodamnia Cinerea And Uses Thereof | BIOTROPICS MALAYSIA BERHAD (MY) | 2015-02-19 | — | — | US | claimed |
| US-8637679-B2 | Process for the isolation of organic compounds useful for the treatment of cancer | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2014-01-28 | — | — | US | claimed |
| US-8541383-B2 | Synergistic phytochemical composition for the treatment of obesity | Laila Nutraceurticals (IN) | 2013-09-24 | — | — | US | claimed |
| WO-2013133685-A1 | EXTRACT FORMULATIONS OF RHODAMNIA CINEREA AND USES THEREOF | BIOTROPICS MALAYSIA BERHAD (MY) | 2013-09-12 | — | — | WO | claimed |
| US-20130065932-A1 | PROCESS FOR THE ISOLATION OF ORGANIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2013-03-14 | — | — | US | claimed |
| US-20100227828-A1 | NEW SYNERGISTIC PHYTOCHEMICAL COMPOSITION FOR THE TREATMENT OF OBESITY | LAILA NUTRACEUTICALS (IN) | 2010-09-09 | — | — | US | claimed |
| EP-4647073-A1 | MURRAYA KOENIGII IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS | Nutraceutical Technology Pharma Biotech S.r.l. (IT) | 2025-11-12 | — | — | EP | disclosed |
| EP-4099976-B1 | MURRAYA KOENIGII EXTRACT AND USE THEREOF IN COSMETICS | GATTEFOSSE SAS (FR) | 2024-12-04 | — | — | EP | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| CN-118141926-A | Application of plant carbazole alkaloid in preparation of iron death inhibitor | 北京大学 | 2024-06-07 | — | — | CN | disclosed |
| US-20060216251-A1 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2006-09-28 | — | — | US | disclosed |
| US-6989165-B2 | Synergistic composition for treating hyperilipdemia | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-01-24 | — | — | US | disclosed |
| WO-2005070442-A1 | A SYNERGISTIC COMPOSITION FOR TREATING HYPERLIPIDEMIA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-08-04 | — | — | WO | disclosed |
| US-20050136138-A1 | Synergistic composition for treating hyperilipdemia | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065932-A1 | PROCESS FOR THE ISOLATION OF ORGANIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER | PSMG3, HSP90B1, HSPA1A | MAPT 1704/4885KMT2A 356/4885MEN1 3075/4885 |
| US-20220143124-A1 | SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION | TNF, COL2A1, ALPI | MAPT 3513/4885KMT2A 911/4885MEN1 3864/4885 |
| US-20060216251-A1 | Topical formulations and methods of use | CPT1B, SLC25A20, CPT1A | MAPT 2476/4885KMT2A 2610/4885MEN1 2963/4885 |
| US-20100227828-A1 | NEW SYNERGISTIC PHYTOCHEMICAL COMPOSITION FOR THE TREATMENT OF OBESITY | BMI1, FABP4, LIPC | MAPT 4730/4885KMT2A 63/4885MEN1 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.